Anja Stefanski
Duesseldorf, NW 40225, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Standardized sample preparation of paediatric bronchoalveolar lavage fluid for mass spectrometry based proteomic analysis.
Journal: Molecular and cellular pediatrics
Published: May 20, 2025
Large extracellular vesicles derived from red blood cells in coronary artery disease patients with anemia promote endothelial dysfunction.
Journal: Journal of molecular and cellular cardiology
Published: May 04, 2025
Multi-omics dissection of MAPK-driven senescence unveils therapeutic vulnerabilities in KIAA1549::BRAF-fusion pediatric low-grade glioma models.
Journal: Signal transduction and targeted therapy
Published: November 06, 2024
Mitochondrial apolipoprotein MIC26 is a metabolic rheostat regulating central cellular fuel pathways.
Journal: Life science alliance
Published: September 10, 2024
The long non-coding RNA OTX2-AS1 promotes tumor growth and predicts response to BCL-2 inhibition in medulloblastoma.
Journal: Journal of neuro-oncology
Published: October 06, 2023
DNA-binding and protein structure of nuclear factors likely acting in genetic information processing in the Paulinella chromatophore.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 26, 2023
Integrative multi-omics reveals two biologically distinct groups of pilocytic astrocytoma.
Journal: Acta neuropathologica
Published: May 11, 2023
Tau protein aggregation associated with SARS-CoV-2 main protease.
Journal: PloS one
Published: March 16, 2023
Mapping the castor bean endosperm proteome revealed a metabolic interaction between plastid, mitochondria, and peroxisomes to optimize seedling growth.
Journal: Frontiers in plant science
Published: March 08, 2023
mTORC1 regulates cell survival under glucose starvation through 4EBP1/2-mediated translational reprogramming of fatty acid metabolism.
Journal: Nature communications
Published: February 05, 2023
Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation.
Journal: Journal for immunotherapy of cancer
Published: December 13, 2022
Targeting CLDN6 in germ cell tumors by an antibody-drug-conjugate and studying therapy resistance of yolk-sac tumors to identify and screen specific therapeutic options.
Journal: Molecular medicine (Cambridge, Mass.)
Published: November 25, 2022
Last Updated: 09/26/2026